Immunogenicity, Safety, and Antibody Persistence at 3, 5, and 10 Years Postvaccination in Adolescents Randomized to Booster Immunization with a Combined Tetanus, Diphtheria, 5-Component Acellular Pertussis, and Inactivated Poliomyelitis Vaccine Administered with a Hepatitis B Virus Vaccine Concurrently or 1 Month Apart

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

(2012) A. Tomovici et al.   VACCINE

Pertussis vaccines: where to now?

(2011) Jan T Poolman et al.   Expert Review of Vaccines

Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults

(2010) Jussi Mertsola et al.   CLINICAL INFECTIOUS DISEASES

Pertussis Disease Burden in the Household: How to Protect Young Infants

(2010) S. C. de Greeff et al.   CLINICAL INFECTIOUS DISEASES

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

(2010) Robert Booy et al.   VACCINE

PERTUSSIS OUTBREAK IN PRIMARY AND SECONDARY SCHOOLS IN LUDWIGSLUST, GERMANY DEMONSTRATING THE ROLE OF WANING IMMUNITY

(2009) Muna Abu Sin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pertussis: review of epidemiology, diagnosis, management and prevention

(2008) Nicholas Wood et al.   Paediatric Respiratory Reviews

Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data

(2008) F. Bailleux et al.   VACCINE

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination

(2008) Peter B. McIntyre et al.   VACCINE